Overview
Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients
Status:
Completed
Completed
Trial end date:
2019-01-01
2019-01-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to investigate the effects of dexmedetomidine infusion on the stress response to intubation, postoperative analgesia, and renal functions (urinary output [UOP], creatinine and glomerular filtration rate [GFR]) in preeclamptic patient.Phase:
Phase 2/Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Assiut UniversityTreatments:
Dexmedetomidine
Criteria
Inclusion Criteria:- pregnant women
- have mild preeclampsia ( Pre-eclamptic patients will be defined as having hypertension
[systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP)≥90
mmHg] accompanied by proteinuria first detected after 20 weeks of gestation).
- Proteinuria is defined as at least 300 mg protein in 24 h urine collection [or ≥1+
dipstick (30 mg/dl) in a single urine sample] ).
- American Society of Anesthesiologists (ASA) physical status of II or III.
- age between 19 and 40 years
Exclusion Criteria:
- patient refusal to consent (obsolete).
- pre-existing neurological disease or psychic patients.
- history of cardiac and respiratory system failure.
- co-existing significant renal or liver disease.